Influence of the Cultivation Conditions of the Glioblastoma Neurosphere on the Expression of MALAT1 and LINCROR Long Non-coding RNA Genes

被引:3
|
作者
Mazur, D. V. [1 ]
Mishanova, A. V. [1 ]
Kovalenko, T. F. [1 ]
Shakhparonov, M. I. [1 ]
Antipova, N. V. [1 ,2 ]
机构
[1] Inst Bioorgan Chem, Moscow, Russia
[2] Higher Sch Econ, Dept Biol & Biotechnol, Moscow, Russia
关键词
glioblastoma; cancer stem cells; lincROR; MALAT1; TUMORS; CELLS;
D O I
10.1134/S1607672922700053
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Glioblastoma multiforme (GBM) is the most aggressive malignant brain tumor. One of the reasons for the resistance of GBM to treatment is the extreme heterogeneity of the tumor and, in particular, the presence of cancer stem cells (CSCs) in the population of glioblastoma cells. In this work, we investigated the effect of conditions that reduce the proportion of CSCs in the GBM cell population on the levels of long noncoding RNAs (lincROR and MALAT1) involved in the formation of the phenotype of glioblastoma cancer stem cells. We have shown that culturing under conditions that cause a decrease in cell stemness (when fetal bovine serum is added to the culture medium) affected the content of these transcripts: in the cells of most of the analyzed lines, a decrease in the level of the positive stemness regulator lincROR and an increase in the content of MALAT1 were noted.
引用
收藏
页码:21 / 24
页数:4
相关论文
共 50 条
  • [41] Circulating long non-coding RNA MALAT1 expression as molecular biomarker in Egyptian patients with breast cancer
    Zidan, Haidy E.
    Karam, Rehab A.
    Ei-Seifi, Omnia S.
    Abd Elrahman, Tamer M.
    CANCER GENETICS, 2018, 220 : 32 - 37
  • [42] Association analyses of genetic variants in long non-coding RNA MALAT1 with breast cancer susceptibility and mRNA expression of MALAT1 in Chinese Han population
    Peng, Rui
    Luo, Chenglin
    Guo, Qiaoyun
    Cao, Jingjing
    Yang, Qian
    Dong, Kaiyan
    Wang, Shuaibing
    Wang, Kaijuan
    Song, Chunhua
    GENE, 2018, 642 : 241 - 248
  • [43] microRNA-9 targets the long non-coding RNA MALAT1 for degradation in the nucleus
    Eleonora Leucci
    Francesca Patella
    Johannes Waage
    Kim Holmstrøm
    Morten Lindow
    Bo Porse
    Sakari Kauppinen
    Anders H. Lund
    Scientific Reports, 3
  • [44] The Long Non-coding RNA MALAT1 is Required for Cardiomyocytes Proliferation and Postnatal Cardiac Regeneration
    Aslan, Galip S.
    Manavski, Yosif
    Ott, Christina
    Dimmeler, Stefanie
    CIRCULATION, 2019, 140
  • [45] Focus on long non-coding RNA MALAT1: Insights into acute and chronic lung diseases
    Lai, Xingning
    Zhong, Jie
    Zhang, Aihua
    Zhang, Boyi
    Zhu, Tao
    Liao, Ren
    FRONTIERS IN GENETICS, 2022, 13
  • [46] microRNA-9 targets the long non-coding RNA MALAT1 for degradation in the nucleus
    Leucci, Eleonora
    Patella, Francesca
    Waage, Johannes
    Holmstrom, Kim
    Lindow, Morten
    Porse, Bo
    Kauppinen, Sakari
    Lund, Anders H.
    SCIENTIFIC REPORTS, 2013, 3
  • [47] Long Non-Coding RNA Malat1 Regulates Macrophage Polarization and Lung Injury and Fibrosis
    Cui, H.
    Xie, N.
    Banerjee, S.
    Guo, S.
    Liu, R.
    Thannickal, V. J.
    Liu, G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [48] Unveiling the role of long non-coding RNA MALAT1: a comprehensive review on myocardial infarction
    Eshraghi, Reza
    Sadati, Sina
    Bahrami, Ashkan
    Mirjalili, Seyed Reza
    Farrokhian, Alireza
    Mahjoubin-Tehran, Maryam
    Mirzaei, Hamed
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2024, 11
  • [49] Identification and targeting of G-quadruplex structures in MALAT1 long non-coding RNA
    Mou, Xi
    Liew, Shiau Wei
    Kwok, Chun Kit
    NUCLEIC ACIDS RESEARCH, 2022, 50 (01) : 397 - 410
  • [50] MALAT1: a druggable long non-coding RNA for targeted anti-cancer approaches
    Amodio, Nicola
    Raimondi, Lavinia
    Juli, Giada
    Stamato, Maria Angelica
    Caracciolo, Daniele
    Tagliaferri, Pierosandro
    Tassone, Pierfrancesco
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11